Addition of atezolizumab to chemotherapy after surgery does not improve survival for triple negative breast cancer

A combined PET-MRI scan could improve treatment for patients with early breast cancer

EBCC 2024: Addressing inequalities across Europe in access to innovation for patients with metastatic breast cancer

Comment: EBCC 2024 highlights

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status

Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients

Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer